Invention Grant
US08969017B2 Metabolite biomarkers for diagnosis and prognosis of pediatric septic shock
有权
代谢物生物标志物用于儿科脓毒性休克的诊断和预后
- Patent Title: Metabolite biomarkers for diagnosis and prognosis of pediatric septic shock
- Patent Title (中): 代谢物生物标志物用于儿科脓毒性休克的诊断和预后
-
Application No.: US14160712Application Date: 2014-01-22
-
Publication No.: US08969017B2Publication Date: 2015-03-03
- Inventor: Beata Mickiewicz , Hans J. Vogel , Hector R. Wong , Brent W. Winston
- Applicant: UTI Limited Partnership , Children's Hospital Medical Center
- Applicant Address: CA Calgary, Alberta US OH Cincinnati
- Assignee: UTI Limited Partnership,Children's Hospital Medical Center
- Current Assignee: UTI Limited Partnership,Children's Hospital Medical Center
- Current Assignee Address: CA Calgary, Alberta US OH Cincinnati
- Agency: Parker Highlander PLLC
- Main IPC: G01N33/53
- IPC: G01N33/53 ; G01N31/00 ; G01R33/465
Abstract:
The present invention provides methods for differentiating a pediatric subject with pediatric septic shock from a healthy pediatric subject or one having sudden inflammatory response syndrome (SIRS). Also provided is a method of predicting pediatric septic shock mortality in a pediatric septic shock patient.
Public/Granted literature
- US20140205591A1 Metabolite Biomarkers for Diagnosis and Prognosis of Pediatric Septic Shock Public/Granted day:2014-07-24
Information query
IPC分类:
